Cipla Limited (CIPLA) — Corporate Action | 26 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Allotment of 5,281 equity shares under ESOS and ESAR schemes
🔄 What Changed
Paid-up capital increased to INR 1,61,57,16,894
💡 Investor Takeaway
This issuance dilutes existing shareholders' ownership proportionally through new employee share allocations.

Cipla announced the allotment of 5,281 fully paid-up equity shares of INR 2 each under its ESOS 2013-A and ESAR 2021 schemes on 26 August 2026, increasing the paid-up share capital to INR 1,61,57,16,894. The issuance reflects ongoing employee incentive utilization without altering overall capital structure or shareholder value metrics.

📄 View Original Announcement (PDF)

About Cipla Limited (CIPLA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,14,390.9 Cr P/E: 33.9 ROE: 9.8% ROCE: 13.2% Div Yield: 0.92%

View full CIPLA stock details →

📡 Get AI alerts when CIPLA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CIPLA — Free

📊 More CIPLA filings

See all CIPLA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CIPLA files new disclosures

Track CIPLA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CIPLA — Free

Free account · 2 AI queries/day